Burak Durmaz

Dr. Burak Durmaz


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2025 in Biochemistry Research International
Verified
Journal Article
Open access
BDBurak Durmaz
Burak Durmaz
LÇLatife Merve Oktay Çelebi
Latife Merve Oktay Çelebi
AÇAyşe Çekin
Ayşe Çekin
AAAyshan Ahadova
Ayshan Ahadova
NGNur Selvi Günel
Nur Selvi Günel
ESESER SÖZMEN
ESER SÖZMEN
Recently, it has been shown that protein phosphatase 2A (PP2A) dysfunction was common in many cancer types and was mediated by various inactivation mechanisms. Although many research studies observed antitumor effect of propolis extracts in various types of cancer, the mechanism of effect are still obscure. In this study, we investigated the effect of propolis on PPP2R1A expression and its relationship with apoptosis in the SW‐620 (colorectal cancer), DU‐145 and PC‐3 (prostate cancer), and MCF‐7 (breast cancer) cell lines, with WI‐38 (healthy fibroblast) cells serving as the control. Moreover, we aimed to investigate the impact of propolis on apoptosis by analyzing apoptosis markers such as tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL), APAF‐1, and caspases‐3, ‐8, and ‐9. Propolis samples were extracted, and their phenolic compounds were quantified using LC‐MS/MS. The RealTime Cell Analysis System‐xCELLigence (RTCA‐SP) device and software were employed to assess cell viability and cytotoxicity of the propolis samples. The IC 50 values for propolis were determined (298 μg/mL for SW‐620, 185.6 μg/mL for DU‐145, 250.7 μg/mL for PC − 3, 292.9 μg/mL for MCF‐7, and 311.2 μg/mL for WI‐38). Subsequently, the effects of propolis on PPP2R1A expression and apoptosis markers (TRAIL, Apaf‐1, and caspases‐3, ‐8, and ‐9) were analyzed. When we compared the healthy cell lines to cancer cell lines, a statistically significant increase in caspase‐3 (3.62‐fold) and in TRAIL (4.38‐fold) was observed in the SW‐620 cell line after the application of propolis. In addition, in the PC‐3 cell line, a 1.4‐fold increase in caspase‐8 was observed compared with the healthy cell line, which is also statistically significant. Our findings indicated that propolis increased the PPP2R1A levels and apoptosis markers in cancer cell lines. It has been suggested that high PPP2R1A levels induced by propolis treatment might activate the apoptosis pathway. In this study, the inducible effect of propolis on PPP2R1A levels, identified as a new target for cancer treatment, was demonstrated for the first time. The findings suggest that propolis holds promise as a potential cancer therapy by increasing PPP2R1A levels, a key molecule in cancer treatment.

1 December 2021 in International Journal of Developmental Neuroscience
Verified
Journal Article
Closed access
PDF file
KÇKübra Çelik
Kübra Çelik
PBPetek Bilim
Petek Bilim
GGGurur Garip
Gurur Garip
BDBurak Durmaz
Burak Durmaz
ESESER SÖZMEN
ESER SÖZMEN
MBMeral Baka
Meral Baka

11 April 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
LÖLütfiye Özpak
Lütfiye Özpak
BBBakiye Göker Bağca
Bakiye Göker Bağca
ÇAÇiğir Biray Avci
Çiğir Biray Avci
CGCumhur Gunduz
Cumhur Gunduz
BDBurak Durmaz
Burak Durmaz
This study aimed to assess the molecular effects of the miR- 155 - 5p in modulating Temozolomide chemosensitivity, which was examined utilizing in silico and in vitro methods on brain cancer stem cells (BCSCs) that exhibit high differentiation, apoptosis avoidance, and a remarkable capacity for self-renewal as a mechanism of chemotherapeutic resistance. The hypothesis of the study is how miR- 155 - 5p modulates temozolomide chemosensitivity in brain cancer stem cells (BCSCs) and their differentiated counterparts (BSCs) and whether it influences the molecular mechanisms underlying tumour recurrence and treatment failure. By silencing miR- 155 - 5p using anti-miR oligonucleotides, the knockdown efficiency of miR- 155 - 5p was confirmed via quantitative qRT-PCR. The increased chemosensitivity effect of miR- 155 - 5p against temozolomide in BCSCs and BCSs was measured by cytotoxicity assay. Subsequently, all studied groups were evaluated by performing cell viability, cell cycle, and apoptosis tests. miRNA-mRNA-pathway interactions were analyzed using different bioinformatics tools and databases. Cell viability was significantly reduced by 42.9% in the combined treatment (anti-miR- 155 - 5p + temozolomide) group compared to the untreated group. Temozolomide treatment in combination with anti-miR- 155 - 5p showed a significant decrease in cell viability compared to temozolomide alone. In contrast, late apoptosis increased 2.10-fold (p < 0.0001), indicating a synergistic effect in promoting late apoptosis. Combining temozolomide and anti-miR- 155 - 5p inhibits DNA synthesis by causing G2 phase arrest. mRNAs targeted by miR- 155 - 5p and significantly down-regulated in glioblastoma included GABRA1, GABRB2, SCN1A, GRIN2A, and SGIP1. By survival analysis, low expression of SCN1A was associated with poor prognosis (p < 0.05; HR = 0.7), highlighting its potential prognostic role. The combination of temozolomide treatment with suppression of miR- 155 - 5p may provide a more effective and side-effect minimized brain cancer treatment strategy by reducing resistance.

3 November 2023 in Cytokine
Verified
Journal Article
Closed access
OÇOznur Çopur
Oznur Çopur
HYHAVVA YAZICI
HAVVA YAZICI
ECErhan Canbay
Erhan Canbay
BDBurak Durmaz
Burak Durmaz
ECEbru Canda
Ebru Canda
ESESER SÖZMEN
ESER SÖZMEN

31 March 2021 in Ege Tıp Dergisi
Verified
Journal Article
Closed access
PDF file
ŞÖŞahin Öztürk
Şahin Öztürk
BDBurak Durmaz
Burak Durmaz
HMHikmet Memmedov
Hikmet Memmedov
LOLatife Merve Oktay
Latife Merve Oktay
SGSelvi Nur Günel
Selvi Nur Günel
ESESER SÖZMEN
ESER SÖZMEN
Amaç: Makrofajlar doğal immün cevabı başlatan ve patojenle ilk temasta bulunan hücreler olarak kabul edilmektedir. Hem hücreler arası ilişkiler hem de inflamatuar mediyatörlerin salınımı yoluyla doğal immün ve inflamatuar yanıtta etkin rol oynamaktadırlar. İnsan THP-1 lösemi monositik hücreleri, makrofajların in vitro olarak fonksiyonlarını, mekanizmalarını ve sinyal yollarını araştırmak için en çok kullanılan hücre dizisidir. Lipopolisakkarit makrofaj farklılaşmasını başlatmak için yaygın olarak kullanılan uyarıcılar arasında yer almaktadır. Ferulik asidin, indüklenebilir nitrik oksit sentaz, kaspazlar ve siklooksijenaz (COX)-2 dahil olmak üzere proinflamatuar sitokinlerin ekspresyonunu ve/veya aktivitesini inhibe ettiği bilinmektedir. Bu çalışmada, lipopolisakkarit ile indüklenen THP-1 monosit hücrelerinde Ferulik asidin sitokin (COX-1, IL-lα, IL-1β, TNF-α, IL-6, IL-10, NF-kβ ve IFN-y) düzeyleri üzerindeki etkisini araştırmayı amaçladık. Gereç ve Yöntem: TNF alfa seviyeleri farklı konsantrasyonlarda ve zamanlarda LPS eklenerek ölçüldü ve en uygun konsantrasyon ve süre belirlendi. COX-1, IL-lα, IL-lβ, TNF-α, IL-6, IL-10, NF-kβ ve IFN-y'nin sitokin miktarları, inkübasyon sürelerinin sonunda toplanan süpernatanlarda ELISA ile ölçüldü. Bulgular: Ferulik asidin, NF-kβ inhibisyonu ile lipopolisakkarit ile indüklenen THP-1 hücrelerinde artan TNF-α, IL-lα ve IL-lβ ekspresyonunu inhibe ettiğini bulduk. Sonuç: Ferulik asidin LPS ile indüklenen THP-1 hücrelerinde sitokin salınımı üzerindeki etkisinin gösterilmesi, aşırı inflamatuar yanıtın tedavisinde ve oto-immün hastalıklara karşı korunmada etkili olabileceğini düşündürdü.

15 July 2025 in Applied Food Research
Verified
Journal Article
Open access
BDBurak Durmaz
Burak Durmaz
ECErhan Canbay
Erhan Canbay
ŞBŞüra Öztürk Baykan
Şüra Öztürk Baykan
HYHatice Kalkan Yıldırım
Hatice Kalkan Yıldırım
ESEser Yıldırım Sözmen
Eser Yıldırım Sözmen